Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive, Early-Stage Breast Cancer

Autor: Smith, John W., II, Vukelja, Svetislava, Hoffman, Anthony D., Jones, Vicky E., McIntyre, Kristi, Berrak, Erhan, Song, James X., O'Shaughnessy, Joyce
Zdroj: In Clinical Breast Cancer February 2016 16(1):31-37
Databáze: ScienceDirect